BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Shukra Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524632
ISIN Demat
INE551C01044
Book Value (Rs)
1.2397304
NSE Symbol
N.A
Divident Yield %
0.19
Market Cap
(Rs In Cr.)
569
P/E (TTM)
68.42
EPS (TTM)
0.19
Face Value
(Rs)
1
Back
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
15-Feb-25   Hrs IST

Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales10.5818.89 -44
OPM %37.1550.50 -
PBDT4.7910.03 -52
PBT4.099.52 -57
NP3.169.42 -66

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)